(4-amino-2-ethylsulfinylpyrimidin-5-yl)-(5-fluoro-2-propan-2-yloxyphenyl)methanone;[4-amino-2-[(1-methylsulfonylpiperidin-4-yl)amino]pyrimidin-5-yl]-(5-fluoro-2-propan-2-yloxyphenyl)methanone;methane;1-methylsulfonylpiperidin-4-amine
C43H62F2N10O9S3 — CID 158096272
Data last refreshed: (MolForge compound catalog, from PubChem)
About (4-amino-2-ethylsulfinylpyrimidin-5-yl)-(5-fluoro-2-propan-2-yloxyphenyl)methanone;[4-amino-2-[(1-methylsulfonylpiperidin-4-yl)amino]pyrimidin-5-yl]-(5-fluoro-2-propan-2-yloxyphenyl)methanone;methane;1-methylsulfonylpiperidin-4-amine
(4-amino-2-ethylsulfinylpyrimidin-5-yl)-(5-fluoro-2-propan-2-yloxyphenyl)methanone;[4-amino-2-[(1-methylsulfonylpiperidin-4-yl)amino]pyrimidin-5-yl]-(5-fluoro-2-propan-2-yloxyphenyl)methanone;methane;1-methylsulfonylpiperidin-4-amine (PubChem CID 158096272) has the molecular formula C43H62F2N10O9S3 and a molecular weight of 997.23 g/mol. Its IUPAC name is (4-amino-2-ethylsulfinylpyrimidin-5-yl)-(5-fluoro-2-propan-2-yloxyphenyl)methanone;[4-amino-2-[(1-methylsulfonylpiperidin-4-yl)amino]pyrimidin-5-yl]-(5-fluoro-2-propan-2-yloxyphenyl)methanone;methane;1-methylsulfonylpiperidin-4-amine.
Molecular Properties
| Compound Name | (4-amino-2-ethylsulfinylpyrimidin-5-yl)-(5-fluoro-2-propan-2-yloxyphenyl)methanone;[4-amino-2-[(1-methylsulfonylpiperidin-4-yl)amino]pyrimidin-5-yl]-(5-fluoro-2-propan-2-yloxyphenyl)methanone;methane;1-methylsulfonylpiperidin-4-amine |
|---|---|
| PubChem CID | 158096272 |
| Molecular Formula | C43H62F2N10O9S3 |
| Molecular Weight | 997.23 g/mol |
| Exact Mass | 996.38 |
| IUPAC Name | (4-amino-2-ethylsulfinylpyrimidin-5-yl)-(5-fluoro-2-propan-2-yloxyphenyl)methanone;[4-amino-2-[(1-methylsulfonylpiperidin-4-yl)amino]pyrimidin-5-yl]-(5-fluoro-2-propan-2-yloxyphenyl)methanone;methane;1-methylsulfonylpiperidin-4-amine |
| SMILES | C.CC(C)Oc1ccc(F)cc1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N.CCS(=O)c1ncc(C(=O)c2cc(F)ccc2OC(C)C)c(N)n1.CS(=O)(=O)N1CCC(N)CC1 |
| InChI | InChI=1S/C20H26FN5O4S.C16H18FN3O3S.C6H14N2O2S.CH4/c1-12(2)30-17-5-4-13(21)10-15(17)18(27)16-11-23-20(25-19(16)22)24-14-6-8-26(9-7-14)31(3,28)29;1-4-24(22)16-19-8-12(15(18)20-16)14(21)11-7-10(17)5-6-13(11)23-9(2)3;1-11(9,10)8-4-2-6(7)3-5-8;/h4-5,10-12,14H,6-9H2,1-3H3,(H3,22,23,24,25);5-9H,4H2,1-3H3,(H2,18,19,20);6H,2-5,7H2,1H3;1H4 |
| InChIKey | FOSBROXETZMSSN-UHFFFAOYSA-N |
| XLogP | 4.40 |
| TPSA | 286.08 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 17 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 67 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 997.23 |
| LogP ≤ 5 | 4.40 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 17 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158096272 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.